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Tumor necrosis factor alpha (TNF-) receptor-associated factors (TRAFs) play important roles in TNF-
signaling by interacting with downstream signaling molecules, e.g., mitogen-activated protein kinases
(MAPKs). However, TNF- also signals through reactive oxygen species (ROS)-dependent pathways. The
interrelationship between these pathways is unclear; however, a recent study suggested that TRAF4 could bind
to the NADPH oxidase subunit p47phox. Here, we investigated the potential interaction between p47phox
phosphorylation and TRAF4 binding and their relative roles in acute TNF- signaling. Exposure of human
microvascular endothelial cells (HMEC-1) to TNF- (100 U/ml; 1 to 60 min) induced rapid (within 5 min)
p47phox phosphorylation. This was paralleled by a 2.7-  0.5-fold increase in p47phox-TRAF4 association,
membrane translocation of p47phox-TRAF4, a 2.3-  0.4-fold increase in p47phox-p22phox complex formation,
and a 3.2-  0.2-fold increase in NADPH-dependent O2
 production (all P < 0.05). TRAF4-p47phox binding
was accompanied by a progressive increase in extracellular signal-regulated kinases 1 and 2 (ERK1/2) and
p38MAPK activation, which was inhibited by an O2
 scavenger, tiron. TRAF4 predominantly bound the
phosphorylated form of p47phox, in a protein kinase C-dependent process. Knockdown of TRAF4 expression
using siRNA had no effect on p47phox phosphorylation or binding to p22phox but inhibited TNF--induced
ERK1/2 activation. In coronary microvascular EC from p47phox/ mice, TNF--induced NADPH oxidase
activation, ERK1/2 activation, and cell surface intercellular adhesion molecule 1 (ICAM-1) expression were all
inhibited. Thus, both p47phox phosphorylation and TRAF4 are required for acute TNF- signaling. The
increased binding between p47phox and TRAF4 that occurs after p47phox phosphorylation could serve to
spatially confine ROS generation from NADPH oxidase and subsequent MAPK activation and cell surface
ICAM-1 expression in EC.
The cytokine tumor necrosis factor alpha (TNF-) is capable
of activating multiple signal transduction pathways and down-
stream processes in mammalian cells. In endothelial cells
(EC), these processes include the activation of several mem-
bers of the mitogen-activated protein kinase (MAPK) family,
as well as the rapid surface expression of cellular adhesion
molecules such as intercellular adhesion molecule 1 (ICAM-1)
(6, 17). EC surface expression of ICAM-1 is required for the
adhesion of polymorphonuclear neutrophils during vascular
inflammation (27).
Occupation of TNF receptors generally leads to the recruit-
ment of diverse intracellular adaptors which then interact with
other proteins that form part of downstream signal transduc-
tion pathways. With respect to immune and inflammatory re-
sponses, the TNF-receptor-associated factors (TRAF1 to
TRAF6) are thought to serve as scaffold proteins that directly
or indirectly link ligand-occupied receptors of the TNF super-
family to other signaling molecules which subsequently cause
the activation of kinases and transcription factors such as the
MAPKs and NF-B, respectively (2, 30). Although many de-
tails of the proteins involved in TRAF-induced activation of
MAPKs and NF-B have been elucidated (2, 30), the exact
upstream mechanisms through which TRAFs potentiate these
pathways remain unclear. In particular, although several pro-
teins capable of direct interactions with TRAFs have been
described, the precise functions of most of these proteins in
TRAF-mediated signaling are unknown (6).
A separate strand of work has described the involvement of
TNF--induced generation of intracellular reactive oxygen
species (ROS) in downstream signaling, e.g., in EC NF-B
activation and the expression of ICAM-1 (15, 24, 26). TNF-
may stimulate ROS production by several sources, e.g., mito-
chondria (4), but recent studies have strongly suggested that a
major source of ROS is a phagocyte-type NADPH oxidase that
is constitutively expressed in EC (3, 9, 13, 22). The EC
NADPH oxidase complex contains a catalytic cytochrome b558
comprising one p22phox subunit and one Nox subunit and sev-
eral regulatory subunits, namely p47phox, p40phox, p67phox, and
Rac1. The activity of EC NADPH oxidase may be upregulated
by mechanical forces, growth factors, angiotensin II, and cyto-
kines such as TNF-. ROS generated from NADPH oxidase
participate in signaling pathways leading to cell proliferation
and activation (10, 11, 16, 28). The p47phox regulatory subunit
plays a critical role in acute activation of neutrophil NADPH
oxidase; phosphorylation of p47phox is thought to relieve inhib-
itory intracellular interactions and permit the binding of
p47phox to p22phox, thereby increasing oxidase activation (12).
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The p47phox subunit also appears to be important in EC, and
previous studies have shown that TNF--induced oxidant gen-
eration is abolished in EC from mice lacking p47phox or in
wild-type EC transfected in vitro with antisense p47phox cDNA
(7, 20).
However, the involvement of ROS generated by NADPH
oxidase in TNF--induced MAPK activation or ICAM-1 ex-
pression remains unclear. Furthermore, it is unclear what the
role of ROS-dependent signal transduction as opposed to
TRAF-activated pathways is in EC responses to TNF-.
Whereas TRAF-mediated activation of c-Jun N-terminal ki-
nase (JNK) has been quite intensively studied, the involvement
of TRAFs in the activation of extracellular signal-regulated
kinases 1 and 2 (ERK1/2) or p38MAPK is much less understood
(6). Very interestingly, in a recent study a yeast two-hybrid
screen found evidence of an association between TRAF4 and
p47phox (31), raising the possibility that TRAF-mediated and
NADPH oxidase-dependent downstream redox signaling may
in fact be linked. However, another recent report indicated
that TRAF-mediated signal transduction may involve ROS
generation by mitochondria (4). The interrelationship between
TNF--induced p47phox phosphorylation, p47phox-TRAF4 as-
sociation, and oxidase activation and the contribution of ROS
generated by NADPH oxidase to downstream activation of
MAPKs (especially ERK1/2 and p38MAPK) are therefore of
great interest. In the present study, we examined the kinetics of
each of these events in response to the acute exposure of
human microvascular EC (HMEC-1) to TNF-. We also more
directly investigated the roles of both p47phox and TRAF4 in
acute TNF--induced MAPK activation and cell surface ex-
pression of ICAM-1, using coronary microvascular EC
(CMEC) isolated from p47phox/ mice and siRNA-mediated
knockdown of TRAF4, respectively.
MATERIALS AND METHODS
Reagents. 5 (and 6)-Chloromethyl-2,7-dichlorodrofluorescein diacetate
(DCF) was purchased from Molecular Probes. Affinity-purified rabbit polyclonal
antibodies to p47phox and p22phox were a kind gift from F. Wientjes (University
College London, London, United Kingdom). The following antibodies were
obtained from Santa Cruz Biotechnology: goat polyclonal antibodies to p22phox
(C-17), p47phox (C-20), and the corresponding blocking peptides; goat polyclonal
antibody specific to the C terminus of TRAF4 (C-20); anti-phospho-JNK
(Thr183/Tyr185) and anti-pan-JNK polyclonal antibodies; and anti-phospho-
ERK1/2 (Tyr204, E-4) and anti-pan-ERK1/2 monoclonal antibodies. Anti-phos-
pho-p38MAPK (Thr180/Tyr182) and anti-pan-p38MAPK polyclonal antibodies
were obtained from Cell Signaling Technology. Anti--tubulin and anti-phos-
phoserine-specific monoclonal antibodies were from Sigma. The siRNA specif-
ically designed to knock down human TRAF4 protein expression and a scram-
bled negative-control siRNA were purchased from Santa Cruz Biotechnology.
[32P]orthophosphate was purchased from Amersham Biosciences, and phos-
phate-free Dulbecco’s modified Eagle’s medium (DMEM) was purchased from
ICN. Bisindolymaleimide (Bis) was from Calbiochem. All other reagents were
obtained from Sigma except where specified.
Cell culture. p47phox null mice (p47phox/) in a 129sv background were
initially generated by and kindly provided by Jurgen Roes (University College
London) (14). A colony of these animals is established in our institution (23). All
studies conformed to the Guidance on the Operation of Animals (Scientific
Procedures) Act, 1986 (Her Majesty’s Stationery Office, London, United King-
dom). CMEC were isolated from the hearts of 8- to 10-week-old p47phox/ and
matched wild-type mice as described previously (19). Human dermal microvas-
cular EC (HMEC-1) were obtained from the Centers for Disease Control and
Prevention (Atlanta, Ga.) (1). HMEC-1 were cultured in medium 199, and
CMEC were cultured in DMEM, both media being supplemented with 10% fetal
bovine serum, EC growth supplement (50 g/ml), epidermal growth factor (10
ng/ml), vascular endothelial growth factor (0.5 ng/ml), ascorbic acid (1 g/ml),
hydrocortisone (1 g/ml), L-glutamine (2 mmol/liter), penicillin (50 U/ml), and
streptomycin (50 g/ml). CMEC were used at passage 2. For the experiments
with TNF-, adherent cells (90 to 95% confluent) were stimulated with TNF-
(100 U/ml) for 1 to 60 min, washed three times with PBS, detached by scratching,
and snap-frozen in liquid nitrogen.
Detection of ROS production. NADPH-dependent O2 production by EC
homogenate was assessed by lucigenin (5 mol/liter)-enhanced chemilumines-
cence as described previously (20, 21). O2 production was measured in the
absence or presence of NADPH (100 mol/liter). The specificity of the signal for
O2 was confirmed by adding either superoxide dismutase (SOD, 200 U/ml) or
tiron (5 mmol/liter), a nonenzymatic scavenger of O2, to inhibit the O2-
dependent chemiluminescence. Each sample was tested in triplicate, and the
final data were obtained from at least three separate cell cultures. NADPH-
dependent SOD-inhibitable chemiluminescence was determined by subtracting
the signal obtained in the combined presence of NADPH and SOD from the
signal obtained with NADPH alone. Data are expressed as mean arbitrary light
units per minute over a 20-min period.
DCF fluorescence was used as a complementary method for visualization of
ROS production. EC were cultured onto chamber slides, washed in Hanks’
buffer, and then exposed to TNF- (100 U/ml) or buffer alone for 30 min. Cells
were incubated with 10 mol of DCF/liter in Hanks’ buffer for 30 min at room
temperature, and fluorescence was then observed with a Zeiss microscope cou-
pled to a digital imaging system (Improvision) (20). Fluorescence intensity was
quantified microscopically from at least three random fields (1,024 by 1,022
pixels; 269.7 by 269.2 m) per slide (50 cells assessed per slide) and three slides
per experimental condition.
In vitro 32P labeling to assess p47phox phosphorylation. HMEC-1 at 90%
confluence were labeled with [32P]orthophosphate (100 Ci/ml) at 37°C over-
night in phosphate-free DMEM supplemented with 10% fetal calf serum, the
latter having been dialyzed against phosphate-free buffer for 24 h before use.
After free [32P]orthophosphate was washed off, cells were incubated with or
without TNF- (100 U/ml) in Hanks’ balanced salt solution for 15 min. In
experiments with the protein kinase C (PKC) inhibitor Bis (10 mol/liter), Bis
was preincubated with the cells for at least 10 min before the addition of TNF-.
Cells were then washed three times with HBSS, detached by scraping into
ice-cold mild lysis buffer containing 0.5% NP-40, NaCl (0.15 mol/liter), sodium
phosphate (0.01 mol/liter), EDTA (2 mmol/liter), sodium fluoride (50 mmol/
liter), sodium vanadate (2 mmol/liter), and aprotinin (100 U/ml) at pH 7.2. Cells
were immediately frozen in liquid nitrogen and then lysed by sonication. Whole-
cell lysate with a protein concentration of 250 g per sample was used for
immunoprecipitation.
Knockdown of TRAF4 with siRNA. In vitro transfection of HMEC-1 with
siRNA was performed according to the manufacturer’s (Santa Cruz) protocol
with some modifications. Briefly, the day before transfection, HMEC-1 were
seeded at 50% confluence in 60-mm-diameter dishes and cultured in growth
medium without antibiotics for 24 h. The next day, cells were washed in medium
199, and transfection was performed in 2 ml of serum-free medium 199 without
antibiotics. TRAF4-specific or scrambled siRNA was used at a final concentra-
tion of 50 nM, and Lipofectamine 2000 (Invitrogen) was used at 1/250 (vol/vol).
Four hours after transfection was started, 1 ml of medium 199 with 20% serum
was added, and cells were cultured for a further 24 h. After that, the transfection
medium was changed to fresh growth medium without antibiotics for another
20 h. Forty-eight hours after transfection, cells were washed, stimulated with or
without TNF- (100 U/ml) for 30 min, detached by scratching, and snap-frozen
in liquid nitrogen for subsequent analyses.
Immunoprecipitation and immunoblotting. Immunoprecipitations were per-
formed under nondenaturing conditions using NP-40-lysed and sonicated whole-
cell extracts (250 g of protein) diluted in Tris-HCl (0.05 mol/liter)–NaCl (0.25
mol/liter) buffer (pH 7.4) with protease inhibitors, as described previously (22).
p47phox was immunoprecipitated with affinity-purified goat or rabbit polyclonal
antibodies coupled to protein G-agarose beads. Immunoblotting of immunopre-
cipitates was undertaken with affinity-purified rabbit polyclonal antibodies to
p47phox and p22phox or with a goat anti-TRAF4 antibody or an anti-phospho-
serine-specific monoclonal antibody (1:1,000 dilution). Protein isolated from
monocytic U937 cells stimulated with phorbol myristate acetate was used as a
positive control for the expression of NADPH oxidase subunits.
In 32P-labeled lysates, an anti-TRAF4 antibody coupled to protein G-agarose
beads was first used to immunoprecipitate TRAF4 and any associated proteins
(potentially including p47phox). To detect phosphorylated p47phox bound to
TRAF4, the TRAF4 complexes on agarose beads were spun down and washed
three times in mild lysis buffer and p47phox was dissociated from TRAF4 on the
agarose beads by adding 1% (wt/vol) sodium deoxycholate and 0.1% sodium
dodecyl sulfate in 300 l of mild lysis buffer warmed to 37°C for 5 min. Any
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p47phox dissociated was detected by immunoprecipitation using an affinity-puri-
fied anti-p47phox antibody. Gels were dried, and phosphorylated p47phox was
detected by autoradiography. Proteins in cell lysates and immunoprecipitates
were also immunoblotted with antibody to p47phox to assess the amount of total
p47phox recovered.
For the detection of MAPK activation, cell homogenates were immunoblotted
with specific antibodies against pan- and phospho-ERK1/2, p38MAPK, and JNK.
Bands were quantified by densitometry, and values for phospho-MAPK expres-
sion were normalized to the amount of total MAPK per sample.
Preparation of membrane and cytoskeletal fractions. In some experiments, we
studied the cellular membrane protein fraction, which was prepared as described
previously (20). Briefly, cells were detached by scraping and were resuspended in
morpholinepropanesulfonic acid (MOPS)-KOH buffer (MOPS-KOH, 20 mmol/
liter; sucrose, 250 mmol/liter [pH 7.4]) containing phenylmethylsulfonyl fluoride
(1 mmol/liter), EDTA (0.1 mmol/liter), sodium fluoride (50 mmol/liter), sodium
vanadate (2 mmol/liter), leupeptin (2 mol/liter), and pepstatin (2 mol/liter).
Cells were disrupted by quick freezing in liquid nitrogen followed by two cycles
(20 s each) of homogenization (Polytron PT 2100) and two cycles of sonication
at 100 W for 15 s on ice. The homogenate was quickly centrifuged at 200  g for
5 min to remove any unbroken cells. The membrane-enriched fraction was
collected by centrifugation for 60 min at 100,000  g. After another wash, the
final pellets were resuspended in sodium dodecyl sulfate buffer and microcen-
trifuged for 5 min. The protein in the supernatant was used as the membrane
fraction.
The extraction of whole-cell protein into Triton X-100-soluble and -insoluble
(cytoskeleton) fractions was performed as described previously (20). Briefly, cells
were resuspended in ice-cold extraction buffer containing HEPES-Tris (20 mmol
of each/liter), NaCl (0.12 mol/liter), KCl (5 mmol/liter), glucose (10 mmol/liter)
(pH 7.4), EDTA (0.1 mmol/liter), sodium fluoride (50 mmol/liter), sodium van-
adate (2 mmol/liter), leupeptin (2 mol/liter), pepstatin (2 mol/liter), and 2%
Triton X-100. Cells were disrupted by quick freezing in liquid nitrogen followed
by two cycles of sonication at 100 W for 15 s on ice. The whole-cell homogenate
was extracted on ice for 20 min. The Triton X-100-soluble and -insoluble frac-
tions were separated by centrifugation at 14,000  g for 15 min. The supernatant
(Triton X-100-soluble fraction) was removed, and the pellet (Triton X-100-
insoluble cytoskeleton fraction) was washed with Triton buffer to eliminate the
residual soluble element. The cytoskeleton fraction was then resuspended in 0.5
ml of Triton buffer, and the soluble protein concentration was determined with
a Bio-Rad kit and used for immunoprecipitation or immunoblotting.
Immunofluorescence confocal microscopy. EC were cultured onto four-cham-
ber slides until 80 to 90% confluent. Cells were fixed in acetone-methanol (50%
[vol/vol]) and then permeabilized in 0.1% Triton X-100 dissolved in 2% bovine
serum albumin-PBS. Slides were blocked with 20% fetal calf serum in PBS for 30
min at room temperature and incubated with primary antibodies diluted (1/50 to
1/250) in 0.1% bovine serum albumin–PBS for 30 min at room temperature (22).
Biotin-conjugated anti-rabbit immunoglobulin G (IgG) or anti-mouse IgG (1/500
dilution) was used as the secondary antibody and incubated for 30 min. Specific
antibody binding was detected with extravidin labeled with fluorescein isothio-
cyanate (FITC) (green fluorescence) or tetramethyl rhodamine isothiocyanate
(TRITC) (red fluorescence). Normal rabbit or mouse IgG (5 g/ml) was used
instead of primary antibody as the negative control in each case. Confocal
microscopy was performed using a Bio-Rad 1024 system. FITC was excited with
a 488-nm argon ion laser line, and TRITC was excited with a 543-nm green
helium-neon laser line. The emission filters for FITC and TRITC were HQ
515/30 and HQ 580/40, respectively. To avoid bleedthrough, while allowing
optimal emission filters to be used, sequential acquisitions were performed (i.e.,
FITC first followed by TRITC) as described before (22). Images were acquired
under identical conditions of exposure time, light intensity, gain, etc.
Statistics. Data are presented as means  standard deviations of at least three
different experiments for each condition. Six mice per group were used for each
FIG. 2. Assessment of p47phox phosphorylation in p47phox-TRAF4
complexes by sequential immunoprecipitation of 32P-labeled cells.
(A) HMEC-1 were labeled with 32P before being treated with TNF-
(100 U/ml, 15 min) in the presence or absence of Bis (10 mol/liter).
Cell lysates were first immunoprecipitated (IP) with an anti-TRAF4
antibody to recover p47phox-TRAF4 complexes, disrupted with deter-
gent, and then reimmunoprecipitated with an anti-p47phox antibody as
described in Materials and Methods. IB, immunoblotted. Phosphory-
lated p47phox was detected by autoradiography (middle panel). The
same membrane was immunoblotted with an antibody against p47phox
to assess the total amount of p47phox (phosphorylated and nonphos-
phorylated) bound to TRAF4 (bottom panel). The initial TRAF4
immunoprecipitate was immunoblotted with an anti-TRAF4 antibody
(top panel) to confirm equal precipitation of TRAF4. (B) Analysis of
relative proportions of phosphorylated p47phox and total p47phox. Au-
toradiographic and immunoblotted bands were scanned densitometri-
cally, and the backgrounds were subtracted. The ratio of phospho-
p47phox to total p47phox was calculated by dividing density results of
autoradiography by density results of immunoblotting; the results are
expressed as means  standard deviations for three separate cell
cultures and labelings.*, P 	 0.01 compared to control cells; †, P 	
0.01 compared to cells stimulated with TNF- alone.
FIG. 1. Time course of TNF--induced p47phox phosphorylation, p47phox-TRAF4 binding, p47phox-p22phox binding, and NADPH-dependent
SOD-inhibitable O2
 production by HMEC-1. (A) Representative immunoblots. p47phox was immunoprecipitated (IP), and then parallel mem-
branes were immunoblotted (IB) either with a phosphoserine-specific antibody (top panel), an anti-TRAF4 antibody (second panel), an anti-
p22phox antibody (third panel), or an anti-p47phox antibody (fourth panel). (B) The first three panels show quantitative densitometric analyses of
immunoblots. Results are expressed as mean arbitrary absorbance units  standard deviations obtained from three separate experiments. *, P 	
0.01 compared to unstimulated cells (i.e., time zero). The bottom panel shows acute TNF--induced NADPH-dependent, SOD-inhibitable
chemiluminescence (CL) in an HMEC-1 cell homogenate. (C) Control experiment to confirm specific capture of TRAF4 after immunoprecipi-
tation for p47phox. CMEC from p47phox/ mice (KO cells) were transfected with an empty vector or with p47phox cDNA. Immunoprecipitation
was performed for p47phox followed by immunoblotting for TRAF4.
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CMEC isolation, and at least three independent isolates were studied. Compar-
isons were made by one-way analysis of variance or with an unpaired t test as
appropriate. A P value 	0.05 was considered statistically significant.
RESULTS
Effect of acute TNF- stimulation on p47phox phosphoryla-
tion, association with TRAF4, and binding to p22phox in
HMEC-1. To examine the mechanisms through which p47phox
is involved in TNF--induced signaling, we first performed
immunoprecipitation of p47phox and then studied (i) p47phox
phosphorylation, (ii) the binding of p47phox to TRAF4, and
(iii) binding of p47phox to a major NADPH oxidase subunit,
p22phox, in HMEC-1. In unstimulated cells, a very low level of
serine phosphorylation of p47phox was detected with a mono-
clonal antiphosphoserine-specific antibody (Fig. 1A and B, top
panels). TNF- induced a significant increase in the phospho-
p47phox level by 5 min, which peaked at 15 to 30 min and was
maintained at 60 min. The same immunoprecipitate was
probed on a separate membrane with an anti-TRAF4 antibody
(Fig. 1A and B, second panels from the top). In unstimulated
cells, there was a readily detectable association of TRAF4 with
p47phox. The association between these proteins was signifi-
cantly increased after 5 min of TNF- stimulation, peaked at
15 to 30 min (2.7- 0.5-fold increase in binding, P	 0.01), and
then decreased slowly. Note that the total levels of p47phox
were similar between groups (Fig. 1A, bottom panel). To con-
firm that the TRAF4 detected after immunoprecipitation of
p47phox represented specific capture, in negative control exper-
iments we demonstrated that no TRAF4 was detectable after
immunoprecipitation for p47phox in p47phox/ cells (Fig. 1C).
However, after transfection of these cells with p47phox (20)
followed by immunoprecipitation of p47phox, TRAF4 was
readily detected by immunoblotting (Fig. 1C).
The membrane used for assessing p47phox serine phosphor-
ylation was reprobed with a p22phox polyclonal antibody to
assess the relationship between p47phox phosphorylation and
p47phox-p22phox complex formation (Fig. 1A and B, third pan-
els from the top). A low level of p47phox-p22phox protein was
readily detectable in the immunoprecipitate of unstimulated
EC. Along with p47phox phosphorylation, the amount of
p22phox coimmunoprecipitated with p47phox rapidly increased
after TNF- stimulation, being maximal at 
60 min. (2.3- 
0.4-fold increase, P 	 0.01). The bottom panel of Fig. 1A
shows an immunoblot of total p47phox and confirms equal
precipitation of samples.
Aliquots of the protein samples used for detection of p47phox
phosphorylation were also examined for NADPH-dependent
SOD-inhibitable O2
 production measured by lucigenin
chemiluminescence (Fig. 1B, bottom panel). TNF- induced a
significant increase in NADPH oxidase activity within 5 min,
and activity peaked at 
30 min (3.2-  0.2-fold increase, P 	
0.05), broadly in parallel with the time course of the events for
which results are shown in the other three panels of Fig. 1B.
This level of chemiluminescence is equivalent to approximately
2.5 nmol of O2
/min/mg of protein, as assessed by us in pre-
vious studies where we conducted a cytochrome c reduction
assay and a lucigenin assay in parallel under identical condi-
tions (21).
32P labeling to assess the nature of the p47phox species
bound to TRAF4. To directly assess whether the p47phox asso-
ciated with TRAF4 was the phosphorylated species and to
estimate the ratio of phosphorylated to total p47phox bound to
TRAF4, we performed a sequential immunoprecipitation of
TNF--stimulated HMEC-1 labeled with 32P, first immunopre-
cipitating with an anti-TRAF4 antibody and then with an anti-
p47phox antibody (see Materials and Methods). The autoradio-
graphs in Fig. 2A (top panel) demonstrate that in unstimulated
cells, there was a very low level of phosphorylated p47phox
associated with TRAF4. In cells stimulated with TNF- for 15
min, there was a marked increase in p47phox phosphorylation,
which was accompanied by a substantial increase in p47phox
association with TRAF4 (Fig. 2A, top and bottom panels). In
the presence of the pan-PKC inhibitor Bis, both the amount of
p47phox phosphorylation and the total p47phox association with
TRAF4 in TNF--stimulated cells were significantly de-
creased. The figure also confirms equal precipitation of
TRAF4 in this experiment. Figure 2B shows an analysis of the
FIG. 3. Effect of TNF- on association between p47phox and
TRAF4 in the cytoskeleton and membrane fractions of HMEC-1.
(A) TRAF4 was immunoprecipitated (IP) from the Triton X-100-
insoluble (cytoskeleton) fraction, and p47phox was then detected by
immunoblotting (IB) in cells stimulated with TNF- (30 min) either in
the presence or absence of the PKC inhibitor Bis or chelerythrine
(Chel). Immunoblotting for TRAF4 confirmed equal precipitation.
(B) Assessment of translocation and binding to p22phox. p22phox was
immunoprecipitated from the cellular membrane fraction, and p47phox
was detected by immunoblotting. Protein extracted from U937 cells
after stimulation with phorbol myristate acetate was used as a positive
control. Similar results were obtained in two independent experiments.
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relative proportions of phosphorylated p47phox versus total
p47phox in this set of experiments and indicates that after
TNF- stimulation a substantially greater proportion of the
p47phox bound to TRAF4 was the phosphorylated form.
TNF--induced changes in p47phox-TRAF4 association and
localization. Since both NADPH oxidase subunits (13, 22) and
TRAF4 (31) have been reported to be present preferentially in
the detergent-insoluble cytoskeleton fraction, we examined the
effect of TNF- stimulation on the association between p47phox
and TRAF4 in the Triton X-100-insoluble (cytoskeleton) frac-
tion. The amount of p47phox associated with TRAF4 was mark-
edly increased in HMEC-1 stimulated with TNF- (Fig. 3A).
However, this increase was substantially inhibited by either of
two inhibitors of PKC, namely Bis (10 mol/liter) or cheleryth-
rine (5 mol/liter).
In an analogous experiment, the membrane translocation of
p47phox and its binding to p22phox were assessed in cell mem-
brane fractions. As shown in Fig. 3B, after immunoprecipita-
tion with an anti-p22phox antibody and immunoblotting for
p47phox, it was evident that TNF- stimulation markedly in-
creased the amount of p47phox-p22phox complex formation in
the membrane fraction. Furthermore, TRAF4 was also de-
tected in the membrane fraction after TNF- stimulation (Fig.
3B). We were unable to coimmunoprecipitate TRAF4 with
p22phox (data not shown). Figure 3B also shows results of
immunoblotting for CD31, confirming appropriate separation
of membrane fractions.
To assess the effect of TNF- treatment (30 min) on the
interaction between p47phox and TRAF4 and the subcellular
distribution of these molecules in HMEC-1 with an alternative
method, we used immunofluorescence confocal microscopy
(Fig. 4). Cells were double stained by using a rabbit polyclonal
antibody to p47phox (red) and a goat polyclonal antibody to
TRAF4 (green). In unstimulated cells, both p47phox and
TRAF4 had mainly eccentric perinuclear distribution patterns
with very little cell surface membrane labeling. Merging of the
p47phox and TRAF4 images indicated some colocalization of
the two molecules, mainly in the perinuclear region (yellow),
but with evidence also of unassociated p47phox and TRAF4.
After 30 min of exposure to TNF-, the intracellular distribu-
tion of both p47phox and TRAF4 appeared more organized in
reticular patterns extending from the perinuclear region, and
there was clear labeling of the cell surface membrane or sub-
sarcolemmal structures, with colocalization of both molecules,
as indicated by the yellow color in merged images (Fig. 4,
bottom panels, white arrows). In order to confirm the role of
p47phox in TNF--induced translocation of TRAF4, identical
experiments were also performed with CMEC isolated from
wild-type and p47phox/ mice. While treatment of wild-type
CMEC with TNF- resulted in a surface membrane translo-
cation of p47phox-TRAF4 similar to that observed in HMEC-1,
no translocation of TRAF4 was observed in p47phox/ CMEC
(Fig. 4B).
TNF--induced activation of MAPKs in HMEC-1. Next we
examined TNF--induced MAPK phosphorylation. In un-
stimulated cells, there was almost no detectable phospho-
ERK1/2 in HMEC-1 (Fig. 5). TNF- caused a rapid phosphor-
ylation of ERK1/2 within 1 min, with phosphorylation peaking
at 
30 min and being maintained at the same level at 60 min.
The kinetics of TNF--induced ERK1/2 activation paralleled
the kinetics of TNF--induced p47phox phosphorylation and
O2
 production (Fig. 1B).
Similar to ERK1/2, TNF- induced a significant and rapid
increase in p38MAPK phosphorylation within 1 min, with phos-
FIG. 4. Immunofluorescence confocal micrographs of HMEC-1 probed for p47phox and TRAF4. (A) HMEC-1 cultured onto chamber slides
were exposed to TNF- or vehicle for 30 min. Slides were double labeled with a rabbit anti-p47phox polyclonal antibody (left panels, red) and a
goat anti-TRAF4 polyclonal antibody (middle panels, green). The yellow color in the merged images (right panels) indicates a colocalization of
p47phox and TRAF4. The white arrows indicate areas of cell surface membrane labeling. All panels are the same scale. (B) CMEC isolated from
p47phox/ mice and labeled with anti-TRAF4 antibody.
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phorylation peaking at 
30 min and then decreasing. Interest-
ingly, TNF- did not induce a significant increase in JNK
phosphorylation until 60 min of stimulation (Fig. 3), indicating
a divergence between JNK and p38MAPK/ERK1/2 in very early
TNF- signaling.
TNF--induced ROS production and MAPK activation in
wild-type and p47phox/ CMEC. In order to directly assess the
role of p47phox in TNF--induced acute ROS production and
MAPK activation, we studied CMEC isolated from wild-type
and p47phox/ mice. DCF fluorescence was used to detect in
situ ROS generation. TNF- (100 U/ml, 30 min) significantly
increased DCF fluorescence intensity in wild-type CMEC (52.5
 6.2 versus 21.2  4.2 arbitrary units in unstimulated cells; n,
300 cells from three independent experiments; P 	 0.01).
However, as expected, no significant increase in DCF fluores-
cence intensity was found with TNF- in p47phox/ CMEC
(26.7  3.4 versus 34.2  2.7 arbitrary units in unstimulated
cells; P 	 0.01).
Next we examined MAPK activation in wild-type and
p47phox/ CMEC. In unstimulated cells, there were low levels
of phospho-ERK1/2, phospho-p38MAPK, and phospho-JNK
detectable (Fig. 6). Exposure of wild-type cells to TNF- for 30
min significantly increased the levels of phospho-ERK1/2 (2.6-
 0.5-fold) and phospho-p38MAPK (2.1-  0.3-fold) (both P 	
0.05), but the level of phospho-JNK was not significantly al-
tered over this time period. In contrast to wild-type CMEC,
TNF- stimulation of p47phox/ CMEC had no significant
effect on the levels of phospho-ERK1/2 or phospho-p38MAPK
expression (Fig. 6).
To confirm that the p47phox–dependent effects discussed
above were attributable to ROS generation by NADPH oxi-
dase, we examined the effects of a cell-permeable O2
 scav-
enger, tiron (5 mmol/liter), or of a flavoprotein inhibitor, di-
phenyleneiodonium (DPI; 10 mol/liter), on TNF--induced
O2
 production and the activation of ERK1/2, which showed
greater changes than the other MAPKs. Wild-type and
p47phox/ CMEC were preincubated with or without tiron or
DPI for 30 min and then exposed to TNF- (100 U/ml) for a
further 30 min in the continued presence of inhibitor. Cell
homogenates were prepared and examined in parallel for
NADPH-dependent O2
 production by lucigenin chemilumi-
nescence (Fig. 7A) and ERK1/2 phosphorylation by immuno-
blotting (Fig. 7B and C). Both tiron and DPI abolished the
TNF--induced increase in NADPH-dependent O2
 genera-
tion by wild-type cells and also abolished the TNF--induced
increase in ERK1/2 phosphorylation. Interestingly, the levels
of O2
 production and ERK1/2 phosphorylation were reduced
by tiron to a level significantly below the basal level in both
FIG. 5. Time course of TNF--induced MAPK activation in HMEC-1. (A) Representative immunoblots showing expression of phospho-
ERK1/2, phospho-p38MAPK, and phospho-JNK and corresponding total MAPKs after various periods of exposure to TNF-. (B) Densitometric
quantification of expression level of phospho-ERK1/2, phospho-p38MAPK, and phospho-JNK normalized by respective total ERK1/2, p38MAPK, and
JNK expression. Results are means  standard deviations from three independent experiments. *, P 	 0.01 for TNF--stimulated versus
unstimulated (time zero).
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wild-type and p47phox/ cells. These data confirm a major
role of ROS generated from NADPH oxidase in TNF--in-
duced ERK1/2 phosphorylation.
Role of TRAF4 in TNF--induced ERK activation. To di-
rectly assess the role of TRAF4 in TNF--induced MAPK
activation, further experiments were undertaken in which
HMEC-1 were transfected with a specific siRNA to knock
down TRAF4 levels. Figure 8A demonstrates that TRAF4
protein expression was substantially reduced after treatment
with specific siRNA versus treatment with scrambled control
siRNA. In anti-TRAF4 siRNA-treated cells, TNF--induced
activation of ERK1/2 was abolished. Total levels of ERK1/2
and of p47phox were similar in all groups. HEK293 cells, which
are known not to express TRAF4 (6a), showed no activation of
ERK1/2 after exposure to TNF- (Fig. 8A). Knockdown of
TRAF4 expression did not inhibit TNF--induced phosphor-
ylation of p47phox as assessed by antiphosphoserine antibodies
(Fig. 8B, top panel), nor did it affect complex formation be-
tween p47phox and p22phox (Fig. 8B, bottom panel). These data
clearly indicate that not only p47phox but also TRAF4 is re-
quired for the acute activation of ERK1/2 by TNF-.
Role of p47phox and O2
 in TNF--induced acute cell sur-
face expression of ICAM-1. Finally, we investigated the re-
quirement of p47phox for TNF--induced cell surface expres-
sion of ICAM-1 in studies with wild-type and p47phox/
CMEC. In wild-type CMEC, stimulation with TNF- (100
U/ml, 60 min) caused a distinct cell surface expression of
ICAM-1, as assessed by immunofluorescence confocal micros-
copy (Fig. 9, top panels). This effect was inhibited by tiron (5
mmol/liter), confirming the role of O2
 in this process. In
contrast, TNF- stimulation failed to induce surface expres-
sion of ICAM-1 in p47phox/ CMEC (Fig. 9, bottom panels).
Normal rabbit IgG (5 g/ml) was used as a negative control
(Fig. 9, bottom right panel).
DISCUSSION
On the basis of previous studies, it is known that TRAF-
mediated signal transduction is important in TNF--induced
activation of MAPKs, in particular JNK (2, 6, 30). It has also
been reported that TNF--induced ROS generation is in-
volved in EC responses such as the activation of NF-B and
expression of ICAM-1 (15, 24, 26) and that these ROS may
derive from NADPH oxidase (7, 20) or other sources (4).
However, the relative roles of NADPH oxidase activation and
TRAF-mediated signaling in acute EC responses to TNF-
and the interrelationship between these, if any, have been
unclear. The present study addressed this question in EC,
focusing particularly on TNF--induced MAPK activation. We
show that the acute response to TNF- involves a rapid PKC-
dependent phosphorylation of p47phox, an increase in p47phox-
TRAF4 association, translocation of p47phox-TRAF4 to the
cell membrane, increased formation of p47phox-p22phox com-
plexes, and activation of NADPH oxidase and ROS genera-
tion. NADPH oxidase activation leads to a rapid (within 5 min)
activation of ERK1/2 and p38MAPK (but not JNK), which re-
quires both p47phox and TRAF4 since it is inhibited either in
the absence of p47phox or after knockdown of TRAF4. These
results therefore suggest a central role for p47phox-TRAF4
interaction and NADPH oxidase activation in TNF--induced
FIG. 6. MAPK activation in wild-type and p47phox/ CMEC. (A) Representative immunoblots showing expression of phospho-ERK1/2,
phospho-p38MAPK, and phospho-JNK and corresponding total MAPKs with or without TNF- stimulation (30 min). (B) Densitometric quanti-
fication of expression levels of phospho-ERK1/2, phospho-p38MAPK, and phospho-JNK normalized by respective total ERK1/2, p38MAPK, and JNK
expression. Results are means standard deviations from three CMEC isolations (six mice in each group for each isolation) *, P	 0.01 comparing
TNF--stimulated versus unstimulated in each group.
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EC activation of ERK1/2 and p38MAPK. We also find that the
p47phox that associates with TRAF4 upon stimulation with
TNF- is predominantly the phosphorylated species and that
p47phox-TRAF4 interaction is PKC dependent, suggesting that
phosphorylation of p47phox may be an important event in for-
mation of the p47phox-TRAF4 complexes.
TNF- signaling is initiated by its binding to TNF- recep-
tors, which leads to the recruitment of several adaptor proteins
(2, 6). Recently, the TRAFs have been recognized to serve as
scaffold proteins that link the TNF receptors to signaling cas-
cades, including activation of MAPKs and NF-B (6, 30).
TRAF4 is predominately intracellularly located but can be
directed to the cell surface receptor sites where it binds
through its C-TRAF domain (8). In a recent study where
TRAF4 and p47phox were transfected into Phoenix-293 cells,
they were found primarily in the detergent-insoluble cytoskel-
eton fraction of these cells and could bind to each other
through their C termini (31). In the present study, the use of
multiple complementary approaches (including coimmunopre-
cipitation, autoradiography, assessment of cellular fractions,
and confocal microscopy) indicated that a small amount of
p47phox was associated with TRAF4 in unstimulated HMEC-1,
mainly in the perinuclear region in a cytoskeletal fraction.
Upon stimulation with TNF-, however, there was a marked
increase in association between phosphorylated p47phox and
TRAF4, which was accompanied by translocation of the
p47phox-TRAF4 complex to the membrane fraction. Confocal
FIG. 7. Effects of tiron and DPI on TNF--induced ERK1/2 acti-
vation in wild-type and p47phox/ CMEC. (A) NADPH-dependent
O2
 production by wild-type and p47phox/ CMEC homogenates
measured by lucigenin chemiluminescence. Results are expressed as
mean light units (MLU) per minute per milligram of protein. (B) Den-
sitometric quantification of expression levels of phospho-ERK1/2 nor-
malized by total ERK1/2 in wild-type and p47phox/ CMEC. Results
are means  standard deviations from three CMEC isolations (six
mice from each group for each isolation). *, significantly higher (P 	
0.01) value than control unstimulated value; †, significantly lower (P 	
0.01) value than control unstimulated value. (C) Representative im-
munoblot showing ERK1/2 phosphorylation in wild-type and
p47phox/ CMEC stimulated with TNF- or unstimulated in the pres-
ence or absence of tiron or DPI.
FIG. 8. Effect of siRNA-mediated knockdown of TRAF4 on acute
TNF-induced ERK1/2 activation and p47phox phosphorylation in
HMEC-1. (A) Immunoblotting for TRAF4 expression and ERK1/2
activation after anti-TRAF4 siRNA treatment. HEK293 cells, which
do not express TRAF4 endogenously (6a), were used as a negative
control for TRAF4 expression. (B) Assessment of serine phosphory-
lation of p47phox after knockdown of TRAF4. The same blot was
reprobed with an anti-p47phox antibody, while a parallel membrane was
immunoblotted (IB) for p22phox. IP, immunoprecipitated.
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microscopy indicated that at least a component of the p47phox-
TRAF4 complexes was translocated to the cell surface mem-
brane (or subsarcolemmal structures). The kinetics of p47phox
phosphorylation closely paralleled those of p47phox-TRAF4
and p47phox-p22phox complex formation and NADPH oxidase
activation, whereas inhibition of p47phox phosphorylation by
inhibitors of PKC inhibited p47phox-TRAF4 binding and mem-
brane translocation of complexes.
The binding of p47phox to TRAF4 is reported to involve
residues 299 to 390 in the C terminus of p47phox (31), which
also contain a cluster of serine residues that form potential
PKC phosphorylation sites (29). Serine phosphorylation of
p47phox in this region is thought to induce conformational
changes in p47phox needed for NADPH oxidase activation (18).
It is possible that p47phox phosphorylation also facilitates its
interaction with TRAF4. In this regard, it is of interest that
TNF--induced NADPH oxidase activation is reported to in-
volve PKC (7), and atypical PKC isoforms as well as cellular
structural proteins have been reported to be potential binding
partners for TRAF (30). The findings in the current study that
both p47phox and TRAF4 are required for TNF--induced
ERK1/2 activation and that p47phox-TRAF4 binding appears
central to this activation suggest that a p47phox-TRAF4 com-
plex could serve to localize redox-regulated signaling mole-
cules downstream of TRAF4 into close proximity to active
NADPH oxidase. In such a scheme, the level of p47phox phos-
phorylation and its binding to TRAF4 may regulate not only
the local level of intracellular ROS (by activating NADPH
oxidase) but also the spatial confinement of ROS close to
appropriate downstream target proteins, e.g., ERK1/2 and
p38MAPK. Consistent with such a scheme, while knockdown of
TRAF4 did not interfere with p47phox phosphorylation (or
p47phox-p22phox complex formation), it inhibited ERK1/2 acti-
vation. Indeed, there was a close relationship between the
kinetics of TNF--induced p47phox phosphorylation, p47phox-
TRAF4 complex formation, NADPH oxidase activation, and
the phosphorylation of ERK1/2 and p38MAPK. Interestingly,
the levels of phospho-JNK (which may also be activated by
TNF- in a redox-sensitive manner [31]) were not significantly
increased in the first 30 min or so after exposure to TNF- at
a time when ERK1/2 and p38MAPK were significantly phos-
phorylated, indicating a divergent activation of these pathways
and suggesting that JNK activation may be more involved in
later TNF--induced events.
The critical roles of p47phox and NADPH oxidase in medi-
ating acute TNF- signaling were directly demonstrated by
using CMEC from p47phox/ mice in which TNF--induced
ROS production and ERK1/2 and p38MAPK phosphorylation
were abolished. Furthermore, the inhibition of ERK1/2 phos-
phorylation either by tiron, an O2
 scavenger, or by DPI, a
flavoprotein inhibitor, provided corroborative evidence that
the p47phox- and NADPH oxidase-dependent effects were in-
deed attributable to O2
. These findings also clearly indicate
that TNF--induced ERK1/2 activation involves O2
 rather
than some other TRAF-mediated signal.
During inflammation, a rapid increase in the surface expres-
sion of EC adhesion molecules is a prerequisite for the early
transmigration of polymorphonuclear cells through the vessel
wall (25). TNF- dramatically induces adhesion molecule sur-
face expression and EC adhesivity within minutes of challenge
FIG. 9. Immunofluorescence confocal micrographs of wild-type and p47phox/ CMEC showing surface expression of ICAM-1. Nonperme-
abilized CMEC cultured onto chamber slides were stimulated with TNF- (100 U/ml, 60 min) or not stimulated in the presence or absence of tiron.
Cells were then probed for the surface membrane expression of ICAM-1. Normal rabbit IgG (5 g/ml) was used as a negative control (lower right
panel). All panels are the same scale.
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(17). Very recently, the importance of NADPH oxidase in the
regulation of TNF--induced EC adhesion molecule expres-
sion has been suggested by the finding that dominant negative
Rac1 (which may disrupt NADPH oxidase activity) inhibits
TNF--induced expression of ICAM-1, vascular cell adhesion
molecule 1, and E selectin in human aortic EC (5). Among the
adhesion molecules, ICAM-1 serves as a counterreceptor for
leukocyte b2-CD11/CD18 integrins and plays an important
role in the firm adhesion and the stable arrest of polymorpho-
nuclear cells onto EC. In the present study, we focused on very
early (within an hour) TNF--induced surface expression of
ICAM-1. We found that acute TNF--induced early EC sur-
face ICAM-1 expression is p47phox dependent and requires an
intracellular burst of O2
. As shown by confocal microscopy,
acute exposure to TNF- caused cell surface ICAM-1 expres-
sion in wild-type CMEC, which was completely blocked by
preincubation of cells with tiron; the effect was also absent in
p47phox/ CMEC.
In summary, we present evidence in the current report for a
TNF--activated redox signaling cascade in microvascular EC
which involves PKC-dependent phosphorylation of p47phox,
p47phox-TRAF4 binding and translocation, NADPH oxidase
activation, and the specific activation of ERK1/2 and p38MAPK
together with early-onset cell surface expression of ICAM-1.
The level of p47phox phosphorylation and the binding of phos-
phorylated p47phox to TRAF4 may be critical factors in regu-
lating acute TNF- signaling, with TRAF4 serving as a link
between p47phox/NADPH oxidase on the one hand and specific
redox-sensitive targets such as ERK1/2 or upstream MAPK-
activating proteins on the other. These results provide an in-
sight into the potential mechanisms through which NADPH
oxidase-derived ROS may result in spatially confined or selec-
tive TNF--induced redox signaling in EC.
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